BRAINBox Solutions Expands Patent Portfolio for Concussion Diagnostics and Neurodegenerative Disease Testing BRAINBox Solutions announces the growth of its patent portfolio that enhances technology for diagnosing concussions and neurodegenerative diseases.

BRAINBox Solutions Expands Patent Portfolio for Concussion Diagnostics and Neurodegenerative Disease Testing #United_States #Richmond #Neurodegenerative_Diseases #BRAINBox_Solutions #concussion_diagnostics

Advancements in Tau Research: Rainwater Charitable Foundation Announces 2026 Prize Winners The Rainwater Charitable Foundation has recognized groundbreaking research in neurodegenerative diseases with its 2026 Rainwater Prizes, honoring top scientists in the field.

Advancements in Tau Research: Rainwater Charitable Foundation Announces 2026 Prize Winners #United_States #Fort_Worth #Neurodegenerative_Diseases #Rainwater_Foundation #Tau_Research

Megan McGill Takes the Helm as CEO of Brenig Therapeutics to Drive Innovation in Neurodegenerative Treatments Brenig Therapeutics announces the appointment of Dr. Megan McGill as CEO, focusing on advancements in therapies for neurodegenerative diseases driven by innovative discovery platforms.

Megan McGill Takes the Helm as CEO of Brenig Therapeutics to Drive Innovation in Neurodegenerative Treatments #USA #Somerville #Brenig_Therapeutics #Neurodegenerative_Diseases #Megan_McGill

CEO of Klotho Neurosciences to Attend Inaugural Conference in California Klotho Neurosciences announces its CEO will meet investors at the inaugural conference discussing therapies for neurodegenerative diseases.

CEO of Klotho Neurosciences to Attend Inaugural Conference in California #USA #Irvine #Neurodegenerative_Diseases #Klotho_Neurosciences #Joseph_Sinkule

New Study Reveals Behavioral Insights on Medication Prescribing Choices in Neurodegenerative Diseases A pioneering study by Alpharmaxim reveals key insights into how behavior influences medication choices for neurodegenerative disorders, emphasizing the need for optimized strategies.

New Study Reveals Behavioral Insights on Medication Prescribing Choices in Neurodegenerative Diseases #United_Kingdom #Neurodegenerative_Diseases #Medications #Alpharmaxim #Altrincham

Comprehensive Insights Into Multiple System Atrophy Therapy Advancements Expected by 2034 The market for multiple system atrophy is on the rise, promising new therapies to meet unmet needs and improving patient outcomes by 2034.

Comprehensive Insights Into Multiple System Atrophy Therapy Advancements Expected by 2034 #USA #Las_Vegas #DelveInsight #Neurodegenerative_Diseases #Multiple_System_Atrophy

Frontiers | Editorial: Molecular and cellular pathways leading to mitochondrial dysfunction and neurodegeneration: lessons from in vivo models, volume II The second volume of our editorial is a continuation of the first (Hannan et al., 2022) and features two reviews and three research articles that highlight h...

Paper alert. We highlight some recent papers published in our special research edition on mitochondria and neuro-developmental+degenerative diseases at Frontiers. #Mitochondria #Neurodegenerative_diseases #Frontiers_in_Neuroscience
www.frontiersin.org/articles/10....

Mission Therapeutics Reveals New Insights on Mitophagy for Neurodegenerative Disease Treatment Mission Therapeutics' latest publication in Nature Reviews discusses enhancing mitophagy as a promising strategy against neurodegenerative diseases.

Mission Therapeutics Reveals New Insights on Mitophagy for Neurodegenerative Disease Treatment #Cambridge #United_Kingdom #Neurodegenerative_Diseases #Mission_Therapeutics #mitophagy

Arkuda Therapeutics Secures Johnson & Johnson Partnership for Neuronal Health Innovations Arkuda Therapeutics has secured a major deal with Johnson & Johnson to advance lysosomal function enhancers for neurodegenerative diseases, signaling hope for Alzheimer's and Parkinson's treatment improvements.

Arkuda Therapeutics Secures Johnson & Johnson Partnership for Neuronal Health Innovations #USA #Johnson_&_Johnson #Watertown #Neurodegenerative_Diseases #Arkuda_Therapeutics

CND Life Sciences Reveals Groundbreaking Test for Neurodegenerative Disease Diagnosis CND Life Sciences published a study demonstrating the Syn-One Test's effectiveness in diagnosing neurodegenerative diseases accurately.

CND Life Sciences Reveals Groundbreaking Test for Neurodegenerative Disease Diagnosis #USA #Scottsdale #Neurodegenerative_Diseases #CND_Life_Sciences #Syn-One_Test

Exploring the Surge of Pelvic Floor Stimulation Devices: Market Insights and Future Trends The pelvic floor stimulation devices market is projected to grow at an impressive rate, driven by increasing urinary incontinence and innovative products.

Exploring the Surge of Pelvic Floor Stimulation Devices: Market Insights and Future Trends #United_States #Las_Vegas #Medtronic #Pelvic_Floor_Devices #Neurodegenerative_Diseases